%YAML 1.2
---

# This YAML file contains information about all the grants and contracts (current and completed) that fund the Chodera lab
#
# Current grants: http://www.choderalab.org/funding

# Here is an illustrative entry for grants
grant:
    # 'id' is the unique identifier by which the grant is referred to in the publications YAML
  - id: "NIH R01 GM121505"
    # 'title' is the title of the grant
    title: "Quantitative dissection of the origin of kinase inhibitor selectivity"
    # 'type' denotes 'federal', 'industry', 'philanthropy'
    type: federal
    # 'organization' denotes the organization (federal, industrial, or philanthropic) granting the funds
    organization: "National Institutes of Health"
    # 'direct_costs' denotes the total direct cost in dollars to the lab
    direct_costs: 981250
    # project start and end dates in ISO 8601 format (YYYY-MM-DD)
    project_begin: 2017-09-15
    project_end_date: 2022-08-31
    # URL to official grant record, if applicable
    url: "https://public.era.nih.gov/grantfolder/piAppDetails/genericStatus.do?encryptedParam=vglppgLq-x8.uktQknguXWR0u0of-5pOGLUIYcZhKRWcSBKVmGbuGyU."
    # Description of the goal of the project (must be followed by two blank lines)
    description: >
      The goal of this project is to characterize the role of conformational reorganization energetics in achieving 
      targeted kinase inhibitor selectivity.      

grant:
    # 'id' is the unique identifier by which the grant is referred to in the publications YAML
  - id: "NIH R01 GM124270"
    # 'title' is the title of the grant
    title: "The goal of this project is to enable blind community challenges that drive progress toward quantitative accuracy in the field of computational physical modeling of drug-receptor interactions."
    # 'type' denotes 'federal', 'industry', 'philanthropy'
    type: federal
    # 'organization' denotes the organization (federal, industrial, or philanthropic) granting the funds
    organization: "National Institutes of Health"
    # 'direct_costs' denotes the total direct cost in dollars to the lab
    direct_costs: 230352
    # project start and end dates in ISO 8601 format (YYYY-MM-DD)
    project_begin: 2018-09-11
    project_end_date: 2022-08-31
    # URL to official grant record, if applicable
    url: "https://projectreporter.nih.gov/project_info_description.cfm?aid=9521419&icde=41560906&ddparam=&ddvalue=&ddsub=&cr=3&csb=default&cs=ASC&pball="
    # Description of the goal of the project (must be followed by two blank lines)
    description: >
      The goal of this project is to enable blind community challenges that drive progress toward quantitative 
      accuracy in the field of computational physical modeling of drug-receptor interactions.

grant:
    # 'id' is the unique identifier by which the grant is referred to in the publications YAML
  - id: "Relay Therapeutics Collaboration"
    # 'title' is the title of the grant
    title: "Development of efficient open source cloud-enabled free energy based lead optimization algorithms and integrative Bayesian model of experimental biophysical and molecular simulation data"
    # 'type' denotes 'federal', 'industry', 'philanthropy'
    type: industry
    # 'organization' denotes the organization (federal, industrial, or philanthropic) granting the funds
    organization: "Relay Therapeutics"
    # 'direct_costs' denotes the total direct cost in dollars to the lab
    direct_costs: 74074
    # project start and end dates in ISO 8601 format (YYYY-MM-DD)
    project_begin: 2018-04-05
    project_end_date: 2019-04-05
    # URL to official grant record, if applicable
    url: "https://relaytx.com/"
    # Description of the goal of the project (must be followed by two blank lines)
    description: >
      The goal of this project is to develop open source scalable cloud workflows for lead optimization using 
      relative and absolute alchemical free energy calculations, as well as Bayesian integrative modeling 
      techniques for experimental biophysical data and molecular simulations.

grant:
    # 'id' is the unique identifier by which the grant is referred to in the publications YAML
  - id: "Entasis Therapeutics Collaboration"
    # 'title' is the title of the grant
    title: "Development of efficient equilibrium and nonequilibrium algorithms for predicting small molecule porin permeation with potential of mean force methods"    
    # 'type' denotes 'federal', 'industry', 'philanthropy'
    type: industry
    # 'organization' denotes the organization (federal, industrial, or philanthropic) granting the funds
    organization: "Entasis Therapeutics"
    # 'direct_costs' denotes the total direct cost in dollars to the lab
    direct_costs: 74074
    # project start and end dates in ISO 8601 format (YYYY-MM-DD)
    project_begin: 2018-04-05
    project_end_date: 2019-04-05
    # URL to official grant record, if applicable
    url: "http://www.entasistx.com/"
    # Description of the goal of the project (must be followed by two blank lines)
    description: >
      The goal of this project is to develop algorithms and open source tools for efficient equilibrium and 
      nonequilibrium potential of mean force calculations for bacterial porins.

grant:
    # 'id' is the unique identifier by which the grant is referred to in the publications YAML
  - id: "Vir Biotechnology  Collaboration"
    # 'title' is the title of the grant
    title: "Predicting resistance vulnerabilities of an ultra-potent RSV antibody"    
    # 'type' denotes 'federal', 'industry', 'philanthropy'
    type: industry
    # 'organization' denotes the organization (federal, industrial, or philanthropic) granting the funds
    organization: "Vir Biotechnology"
    # 'direct_costs' denotes the total direct cost in dollars to the lab
    direct_costs: 55556
    # project start and end dates in ISO 8601 format (YYYY-MM-DD)
    project_begin: 2019-07-25
    project_end_date: 2021-07-24
    # URL to official grant record, if applicable
    url: "https://www.vir.bio/"
    # Description of the goal of the project (must be followed by two blank lines)
    description: >
      The goal of this project is to develop alchemical free energy methods for predicting the impact of 
      point mutations on antibody:antigen affinities.

grant:
    # 'id' is the unique identifier by which the grant is referred to in the publications YAML
  - id: "Parker Institute for Cancer Immunotherapy Pilot Grant"
    # 'title' is the title of the grant
    title: "Physics-based computational prediction of cancer-associated mutant MHC class II epitopes"    
    # 'type' denotes 'federal', 'industry', 'philanthropy'
    type: philanthropy
    # 'organization' denotes the organization (federal, industrial, or philanthropic) granting the funds
    organization: "Parker Institute for Cancer Immunotherapy"
    # 'direct_costs' denotes the total direct cost in dollars to the lab
    direct_costs: 75000
    # project start and end dates in ISO 8601 format (YYYY-MM-DD)
    project_begin: 2018-04-02
    project_end_date: 2019-04-01
    # URL to official grant record, if applicable
    url: "https://www.parkerici.org/"
    # Description of the goal of the project (must be followed by two blank lines)
    description: >
      None

grant:
    # 'id' is the unique identifier by which the grant is referred to in the publications YAML
  - id: "MSKCC Functional Genomics Initiative"
    # 'title' is the title of the grant
    title: "Integrated approaches annotate functions of cancer-associated H3K36 methyltransferases"    
    # 'type' denotes 'federal', 'industry', 'philanthropy'
    type: philanthropy
    # 'organization' denotes the organization (federal, industrial, or philanthropic) granting the funds
    organization: "MSKCC"
    # 'direct_costs' denotes the total direct cost in dollars to the lab
    direct_costs: 25000
    # project start and end dates in ISO 8601 format (YYYY-MM-DD)
    project_begin: 2018-12-01
    project_end_date: 2020-11-30
    # URL to official grant record, if applicable
    url: "https://www.mskcc.org"
    # Description of the goal of the project (must be followed by two blank lines)
    description: >
      The goal of this project is to use a combined experimental-computational approach to annotate the 
      functional impact of clinical cancer mutations in H3K36 methyltransferases

grant:
    # 'id' is the unique identifier by which the grant is referred to in the publications YAML
  - id: "Einstein BIH Visiting Fellowship"
    # 'title' is the title of the grant
    title: "Computational polypharmacology: A new paradigm for selectively promiscuous kinase inhibitors"    
    # 'type' denotes 'federal', 'industry', 'philanthropy'
    type: philanthropy
    # 'organization' denotes the organization (federal, industrial, or philanthropic) granting the funds
    organization: "Stiftung Charité - Einstein Foundation"
    # 'direct_costs' denotes the total direct cost in dollars to the lab
    direct_costs: EIR 150000
    # project start and end dates in ISO 8601 format (YYYY-MM-DD)
    project_begin: 2019-02-01
    project_end_date: 2022-01-31
    # URL to official grant record, if applicable
    url: "https://www.stiftung-charite.de/funding/the-private-excellence-initiative-johanna-quandt/?L=1"
    # Description of the goal of the project (must be followed by two blank lines)
    description: >
      The goal of this project is to develop open source tools for integrating structure-informed machine 
      learning and alchemical free energy calculations for the design of selectively promiscuous kinase inhibitors.




























































